SCHEMBL26074262

SCHEMBL26074262

C#CC(=O)N1CCN(c2cccc(-c3cc4onc(NS(=O)(=O)c5c(OC)cccc5OC)c4cc3C)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 18/20 0.48
KAT7 O95251 17/20 0.48
KAT6B Q8WYB5 13/20 0.48
KAT5 Q92993 9/20 0.48
KAT8 Q9H7Z6 9/20 0.48
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
PKM P14618 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30545863 1.00 KAT6A (0.48) KAT6AKAT7KAT6BKAT5KAT8
SCHEMBL26074264 0.87 KAT6A (0.48) KAT6AKAT7KAT6BKAT5KAT8
SCHEMBL30545813 0.87 KAT6A (0.48) KAT6AKAT7KAT6BKAT5KAT8
SCHEMBL31336106 0.85 KAT6A (0.50) KAT6AKAT7KAT6BKAT5KAT8
SCHEMBL26074263 0.85 KAT7 (0.53) KAT6AKAT7KAT6BKAT5KAT8
SCHEMBL26074052 0.85 KAT6A (0.53) KAT6AKAT7KAT6BKAT5KAT8
Hydrochloric Acid SCHEMBL26124455 0.84 KAT7 (0.52) KAT6AKAT7KAT6BKAT5KAT8
Hydrochloric Acid SCHEMBL31120838 0.84 KAT7 (0.52) KAT6AKAT7KAT6BKAT5KAT8
SCHEMBL30545722 0.82 KAT6A (0.50) KAT6AKAT7KAT6BKAT5KAT8
SCHEMBL26074165 0.82 KAT6A (0.50) KAT6AKAT7KAT6BKAT5KAT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4499609-A1 INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES Isosterix, Inc. (US) 2025-02-05 EP disclosed
US-12187732-B2 Inhibitors of the myst family of lysine acetyl transferases Isosterix, Inc. (US) 2025-01-07 US disclosed
US-11976075-B2 Inhibitors of the MYST family of lysine acetyl transferases Isosterix, Inc. 2024-05-07 US disclosed
US-11976075-B2 Inhibitors of the MYST family of lysine acetyl transferases Isosterix, Inc. 2024-05-07 US disclosed
US-11976075-B2 Inhibitors of the MYST family of lysine acetyl transferases Isosterix, Inc. 2024-05-07 US disclosed
US-20230416260-A1 Inhibitors of the MYST Family of Lysine Acetyl Transferases Isosterix, Inc. 2023-12-28 US disclosed
WO-2023192817-A1 INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES Isosterix, Inc. (US) 2023-10-05 WO disclosed
WO-2023192817-A1 INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES Isosterix, Inc. (US) 2023-10-05 WO disclosed
US-20230303580-A1 INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES Isosterix, Inc. 2023-09-28 US disclosed
US-20230303580-A1 INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES Isosterix, Inc. 2023-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230416260-A1 Inhibitors of the MYST Family of Lysine Acetyl Transferases KAT6A, KAT6B, KAT2A KAT6A 1/4885KAT7 4/4885KAT6B 2/4885
US-12187732-B2 Inhibitors of the myst family of lysine acetyl transferases KAT6A, KAT6B, KAT2A KAT6A 1/4885KAT7 4/4885KAT6B 2/4885
US-20230303580-A1 INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES KAT6A, KAT6B, KAT2A KAT6A 1/4885KAT7 4/4885KAT6B 2/4885
US-11976075-B2 Inhibitors of the MYST family of lysine acetyl transferases KAT6A, KAT6B, KAT2A KAT6A 1/4885KAT7 4/4885KAT6B 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.